FDA Advisory Committee Recommends Licensure Of New Pediatric Combination Vaccine
Fri, 26 Jan 2007 08:00 AM EST
... Sanofi pasteur, the vaccines business of the sanofi-aventis Group (NYSE: SNY; EURONEXT: SAN), is pleased that the members of an advisory committee to the U.S. Food and Drug Administration (FDA) voted nearly unanimously today that the company's pentavalent combination vaccine for use in pediatric patients is both safe and efficacious. [click link for full article] ...
Related Topics
- Bioethics
- Dietary Guidelines
- Vaccine
- Children's Health
- Polio Vaccine & Cancer
- Hepatitis A Vaccine
- Polio Vaccine
- Polio Vaccine & Origin of HIV/AIDS
- Pediatric Care
- Vaccine Side Effects
- MMR Vaccine & (Asceptic) Meningitis
- Smallpox Vaccine
- Pediatric Aids
- Chickenpox Vaccine
- Combination Vaccines
- Hepatitis A and Hepatitis B Vaccine
- Hepatitis B Vaccine
- Pneumococcal Vaccine
- Anthrax Vaccine
- Rotavirus Vaccine & Intussusception

Not Signed In -

